TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | 1 | 1 | 5 | 6 | 1 | -3 | 2 |
| S | %wins | 0 | 50 | 50 | 50 | 50 | 50 | 42 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/2/14 14:51 | 12/1/14 | VIVO | Meridian Bioscience Inc | OH | Health | Diagn | In Vitro & In Vivo Diagnostic | Rolih Susan | OH | O | EVP,Reg, | S.d | -185 | 16.46 | 6 | -11 | -9 | 117 | D | -11 | -30 | -15 | -14 | -6 | -3 | 2 | 0 | 1 | 1 | 0 | 23 | 16 | 24 |
11/26/13 11:50 | 11/22/13 | VIVO | Meridian Bioscience Inc | OH | Health | Diagn | In Vitro & In Vivo Diagnostic | Rolih Susan | OH | O | EVP,Reg, | S.d | -220 | 24.18 | 4 | -9 | -8 | 107 | D | 47 | 21 | 12 | 7 | 2 | -3 | -2 | -1 | 1 | 0 | 9 | -12 | -14 | -29 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |